Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1305 - 1312 of 11616 results
21 Law Firms Touted By Legal Aid Group For DEI Efforts
April 14, 2023| News
OCR Proposes HIPAA Amendments to Protect Reproductive Health Care Information
April 13, 2023| Blog| Viewpoint
FTC Sends Notice of Potential Penalties to Approximately 670 Companies Regarding Substantiation of Advertising Claims
April 13, 2023| Blog| Viewpoint
Mintz Attorneys Discuss Rulings in BIPA Class Action Lawsuits
April 13, 2023| News
CMS Builds Upon Interoperability Rules with Prior Authorization Proposal
April 12, 2023| Blog| Viewpoint
Mintz Taps Ex-FCC Legal Adviser As Technology Co-Chair
April 12, 2023| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.